Showing results (3151-3160 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 1, 1992
A phase II trial of CI-921 in advanced malignanciesN T Sklarin, P H Wiernik, W R Grove, et al.
Investigational New Drugs|November 1, 1992
Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group studyE H Kraut, J Bendetti, S P Balcerzak, et al.
Investigational New Drugs|October 25, 2007
A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell linesPiotr Jasinski, Brandon Welsh, Jorge Galvez, et al.
Investigational New Drugs|November 15, 2007
Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cellsAxel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, et al.
Investigational New Drugs|November 27, 2007
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neckPatricia A Tang, Lillian L Siu, Eric X Chen, et al.
Investigational New Drugs|October 2, 2007
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2Miguel Muñoz, Marisa Rosso, Francisco J Aguilar, et al.
Investigational New Drugs|October 1, 2008
Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitorsJoanna Fraczek, Sarah Deleu, Aneta Lukaszuk, et al.
Investigational New Drugs|September 6, 2008
The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cellsBlazej Rubis, Mariusz Kaczmarek, Natalia Szymanowska, et al.
Investigational New Drugs|September 20, 2008
p53-dependent antiproliferative and antitumor effect of novel alkyl series of diorganotin(IV) compoundsBiplob Koch, Tushar S Basu Baul, Anupam Chatterjee
Investigational New Drugs|August 1, 1991
Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641R L Schilsky, D Faraggi, A Korzun, et al.
Pageof 372